Navigation Links
Valeant Pharmaceuticals Reports Fourth Quarter and Full Year Financial Results
Date:2/24/2009

y.

Research and development costs decreased 60% to $11.9 million in the 2008 fourth quarter as compared to $29.4 million reported in the same period in 2007. This decrease is due to the effect of the GSK collaboration, as well as cost reduction efforts by the company. Under collaboration accounting R&D spending in the quarter on the collaboration was offset by a credit from the initial upfront payment.

In the fourth quarter, the company recorded purchased in-process research and development charges of $186.3 million, related primarily to the previously announced acquisition of Dow Pharmaceutical Sciences, Inc. The company also recorded restructuring, asset impairment and disposition expenses of $17.0 million in the quarter.

Loss from continuing operations was $150.5 million for the fourth quarter of 2008, or a loss of $1.82 per diluted share as compared to income from continuing operations of $2.1 million, or $0.02 per diluted share for the fourth quarter of 2007. Valeant intends to continue to buy assets in the future, which means that company financials will be subject to certain adjustments for purchase accounting that could significantly change GAAP EPS. Valeant believes that excluding these adjustments, such as acquired in-process research and development (IPR&D), restructuring, asset impairments and dispositions, amortization expense, gain on early extinguishment of debt and the tax effect of such changes, facilitates investors' understanding of the trends in the company's underlying business. Therefore, the company uses a Cash EPS metric to evaluate company financial performance. On a non-GAAP basis, or Cash EPS basis, adjusted income from continuing operations was $43.2 million or $0.52 per diluted share in the fourth quarter of 2008 as compared to adjusted income from continuing operations of $25.1 million, or $0.28 per diluted share in the fourth quarter of 2007. For the full 2
'/>"/>

SOURCE Valeant Pharmaceuticals International
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. Three Rivers Pharmaceuticals(R), LLC Acquires Hepatitis C Drug Infergen(R) from Valeant Pharmaceuticals
2. Valeant Pharmaceuticals to Announce 2008 Fourth Quarter and Year Results on February 24, 2009
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
6. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
10. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
11. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... From first-hand experience, Matthew O'Farrell knows all about ... can be treated. , A medically retired Army veteran, ... platoon sustained multiple attacks resulting in five casualties. After ... PTSD and honorably discharged from the Army. , “I ... myself from my friends and family,” recalled O’Farrell, who ...
(Date:9/23/2014)... By Karen Pallarito ... -- Imagine if doctors and hospitals got paid for providing ... consumers had better data for making informed health choices. ... health system is headed. The report, from the IMS ... of change" -- recent events expected to alter the delivery ...
(Date:9/23/2014)... 2014 What information do patients ... Quality Forum (NQF) released a report ( http://bit.ly/1DwekE9 ... an infographic ( http://bit.ly/1tX3lzA ) resulting from an ... how patients define affordability, and what information and ... best possible healthcare at the lowest possible cost. ...
(Date:9/23/2014)... A recent Oregon survey about an exercise DVD that ... routine of elementary school students found it had a ... and offered clear advantages for overly sedentary educational programs. ... produced by the Healthy Youth Program of the Linus ... nationally. , Brain Breaks leads children in 5-7 minute ...
(Date:9/23/2014)... 23, 2014 Trevera provides multiple ... Included are Oracle Managed Services , Oracle ... all versions of Oracle E-Business Databases and ... , Trevera has announced a significant enhancement to ... help with their software technology management, project management, ...
Breaking Medicine News(10 mins):Health News:Virtual Reality software to help treat PTSD 2Health News:Virtual Reality software to help treat PTSD 3Health News:Report Identifies Game Changers for U.S. Health Care 2Health News:Report Identifies Game Changers for U.S. Health Care 3Health News:Finding Affordable Care: Asking the Right Question is Key 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 3Health News:Trevera, Inc adds Management Support to Services 2Health News:Trevera, Inc adds Management Support to Services 3
... Swaroop Rani Nehru Hospital (SRN hospital) has resumed function, ... //. Two old dialysis machines have been repaired and ... ,Following inspection by the Medical Council of India ... machines. The patients are being charged for Rs 500 ...
... study published in PLoS Pathogens says that researchers have ... bacterium, which belongs to the family Acetobacteraceae is a ... the vinegar-making industry. ,The bacterium was identified ... is a rare genetic disorder that compromises the immune ...
... For the first time researchers have studied deeply about fat ... in the heart .Research has now revealed that these Fat ... of heart disease. University of Iowa researchers have revealed that ... ,Fat cells, once upon a time, were thought to have ...
... vegetables in your diet helps you to have fewer wrinkles ... // ,People with a normal diet can make ... red paprika in their meals, German magazine The Dermatologist said ... oxygen molecules - are a major factor in premature skin ...
... to a new study, lack of sleep in children, ... the University of Laval's faculty of medicine studied 422 ... the weight, height, and waist size of each participant. ... lifestyle and socio-economic status through phone interviews with their ...
... with cancer are interested in finding about latest treatments ... support //, reveals a new cancer study. Clive Seale, ... that cancer reaction is linked to gender. The findings ... to cancer support groups that help cancer patients. ...
Cached Medicine News:Health News:Fat cells lethally connected to heart disease 2Health News:Gender Difference In Reaction To Cancer 2
(Date:9/23/2014)...  SI-BONE, Inc., a medical device company that pioneered ... a minimally invasive surgical (MIS) device indicated for fusion ... U.S. Patent and Trademark Office has awarded the company ... fixation and fusion of bone.  This newly issued patent ... may be placed from one bone across a joint ...
(Date:9/23/2014)... NEW YORK , September 23, 2014 ... nouvelle solution Face2Gene améliorée lors d,une série ... http://www.fdna.com ), pionnier dans le domaine de ... exposera sa solution au stand n° 1035 lors ... à San Diego , ...
(Date:9/23/2014)... , Sept. 23, 2014   MedNet Solutions , a ... systems, is pleased to announce that it will once again ... Management (SCDM) Annual Conference, to be held this year from ... , Nevada. MedNet team members, in conjunction with representatives from ... who will also be in attendance, will be providing demonstrations ...
Breaking Medicine Technology:SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 2SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 3FDNA exposera sa solution Face2Gene intégrée en ligne avec London Medical Databases (LMD) à l'ASHG 2014 2FDNA exposera sa solution Face2Gene intégrée en ligne avec London Medical Databases (LMD) à l'ASHG 2014 3MedNet Solutions - Proud To Sponsor The SCDM 2014 Annual Conference 2
... facilitates stomal insertion., ,Adult TTS™ Adjustable ... trach tie, disconnect wedge, and obturator/introducer device., ... are intended for temporary use until the ... be obtained. Not for home care use. ...
... Lo-Profile™ tracheostomy tube is cosmetically pleasing ... styles of inner cannula come with ... cannula and a 15 mm ISO ... The semi-reusable inner cannula may be ...
... mm ISO termination for easy ventilator circuit ... place. , ,Clearly the softer choice ... , ,The Portex® flexible disposable inner ... polyvinyl chloride, providing a softer and more ...
... TRACH CARE Dual Lumen, allows ... the patient end of the ... Swivel Elbow and Direction Tip ... Offers multiple tracheostomy sizes, French ...
Medicine Products: